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QUANTIFICATION OF MULTI-LUMEN BLOOD VESSEL PATHOLOGY IN 
CHRONIC TRAUMATIC ENCEPHALOPATHY 
KEVIN DELL’AQUILA 
ABSTRACT 
Background Chronic Traumatic Encephalopathy (CTE) is a neurodegenerative disorder 
that had been largely ignored for decades since its initial characterization in 1928 by Dr. 
H. Martland. Within the last several years, a dramatic increase of attention in the media 
has been given to the subject and is now a household term. As a consequence of 
repetitive concussive and subconcussive events, CTE has been clearly distinguished form 
other neurodegenerative disorders such as Alzheimer’s Disease and Parkinson’s.  Its 
prominence in military personnel and professional athletes has established the importance 
for its characterization in order to develop preventative approaches and regulations. 
Recently, characterization and staging of CTE has been achieved and interventional 
approaches are already being implemented in response to this increased understanding. 
However, not everything is known about the pathology and its underlying mechanisms. 
No known studies have been done to quantify the connection between MLV pathology 
and CTE.  
Objective: To determine if MLV pathology observed in CTE may serve as a potential 
biomarker. 
Methods: The white and grey matter of brains from subjects with CTE and control 
subjects without CTE were analyzed for the presence and characteristics of multilumen 
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vessels (MLVs) in the dorsolateral frontal cortex (DLFC). A total of 123 slides were 
analyzed, 88 from CTE cases and 35 from Non-CTE cases. The quantification of 
overrepresented MLVs and their features was the primary endpoint of the study. 
Associations were then made between the characteristics of multilumen vessels and 
controlling factors such as age at death and years of exposure to repetitive head injuries 
(RHIs). Finally, regression analysis was used to test for the predictive qualities of the 
density and average number of lumen for stage of CTE while controlling for age at death 
and years of exposure. 
Results: It was found that MLVs are overrepresented in the CTE cohort in comparison to 
the Non-CTE cohort. There is also a possible connection between the presence of MLVs 
with their pathologic observable features to the progressive nature of CTE. In addition, 
the MLVs found in CTE have observable characteristics that are dissociable from MLVs 
in Non-CTE. Furthermore, for increased confidence of the findings, results remain 
significant even with the application of stricter parameters for defining MLVs. Finally, 
there was evidence of a connection between the development of MLVs to the progression 
of CTE. 
Conclusions: The findings suggest there is a strong relationship between age of death 
and the frequency of MLVs. Furthermore, the development of MLVs is likely positively 
impacted by the progression of CTE. 
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INTRODUCTION 
History of Chronic Traumatic Encephalopathy 
Throughout the last decade, there has been growing awareness and concern regarding the 
consequences associated with repetitive head injuries (RHIs), especially with respect to 
athletes and military personnel (McKee 2010, McKee 2013, McKee 2014). A potential 
neurodegenerative result of RHI is chronic traumatic encephalopathy (CTE). CTE was 
originally coined “punch drunk syndrome,” in 1928 by Dr. H. Martland who identified 
the pathology by studying the brains of deceased boxers. Martland identified “Punch 
drunk” by the observation of motor symptoms and a deteriorating cognitive condition in 
boxers, and confirmed the pathology by post-mortem observation of the gross anatomy 
which included hemorrhages leading to scarring and cerebral atrophy. In 1937 the 
pathology was coined ‘dementia pugilistica’ by Millspaugh, and finally chronic traumatic 
encephalopathy in 1940 by Bowman and Blau. Seminal studies and high-profile cases 
have refined an understanding of the disease and has brought CTE to public awareness.  
The initial understanding of CTE was taken solely from boxers, but the following years 
brought forth a more comprehensive view of neuropathological consequences of head 
trauma. Recognition of its presence in American football and other sports began with 
Bowman and Blau in 1940, who reported “this condition was known for a long time to 
the lay public,” and seen “in professional pugilists and football players.” Corsellis in 
1959 used a clinical study of a deceased middle-aged man who suffered a traumatic brain 
injury to add to the lacking clinical and histological information on the topic of 
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pathologies following head trauma. The striking similarity between traumatic 
encephalopathy and Alzheimer’s precluded a confident diagnosis from Corsellis of either 
primary or comorbid Alzheimer’s or primary “insidious dementia” resulting from the 
head injury. However, he did gather sufficient evidence to claim the presence of 
Alzheimer’s with head trauma could be a coincidence, suggesting that the pathology 
following head trauma is dissociable from Alzheimer’s disease. With few contradictions 
in the literature, most prominent historical and modern studies on CTE have 
demonstrated consistency in the presentation of CTE. The disease presents itself in a 
nonspecific way to any particular sport or activity with exposure to repetitive head 
injuries (Scully F. 1937, Martland HS 1928, Bowman & Blau 1940). The prevalence of 
CTE in sports, especially in football, had been largely ignored in the following decades 
until recently with a high profile autopsy in 2005 performed by Bennet Omalu on 
deceased National Football League (NFL) player Mike Webster.  Since then, CTE has 
been characterized clinically, anatomically, and histologically and can only be diagnosed 
post-mortem (McKee 2013). Applications of the deepened understanding are also being 
increasingly established (Smith AM 2015). 
 
Characterization of CTE 
Clinical presentation 
Chronic traumatic encephalopathy has been clearly dissociated from other 
neurodegenerative diseases such as Alzheimer’s disease (Montenigro PH 2015).  
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Provisional research criteria for diagnosing the clinical manifestation of CTE during life 
have been proposed (e.g., Traumatic Encephalopathy Syndrome; TES) (Montenigro PH 
2014). CTE presents clinically with two possible subtypes that often co-occur: early- to 
mid-life behavioral/mood disturbances (e.g. irritability, depression), and later-life 
cognitive impairment (e.g., executive and episodic memory dysfunction) (Stern RA 
2013). It is unclear how the two subgroups become differentiated, but it is possible that 
the subgroups are formed by alternative biomechanics associated with different sports. 
How the biomechanics of head trauma affect quantifiable features of MLVs in CTE was 
not explored in this study. 
 
Pathology 
The neuropathological diagnosis of CTE is made using the NINDS consensus criteria for 
CTE that are based on the presence of abnormal perivascular accumulations of 
hyperphosphorylated tau in neurons, astrocytes, and cell processes in an irregular and 
patchy distribution concentrated at the depths of cortical sulci (McKee AC 2016).  
Supportive features include superficial NFTs and subpial astrocytic tangles in cerebral 
cortex at sulcal depths (McKee 2013). Anatomically the distinctive pathology includes 
but is not limited to a reduction in brain weight, dilation of ventricles and cerebral 
aqueduct, septal abnormalities, mammillary body atrophy and thinning of the corpus 
callosum. 
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STAGING OF CTE 
CTE has been characterized into four stages 
Anatomically, stage I may include mild lateral ventricular enlargement (otherwise no 
gross features), and focal epicenters of perivascular p-tau neurofibrillary and astrocytic 
tangles, most prominent in sulcal depths and typically affecting superior and dorsolateral 
frontal cortices with surrounding cortex largely unaffected. TDP-43 may also be found in 
frontal subcortical white matter and fornix. Stage II may demonstrate mild enlargement 
of frontal horn of lateral ventricles or 3rd ventricle, cavum septum, 3rd ventricle 
enlargement, pallor of locus coeruleus and substantia nigra and P-tau pathology diffusely 
around most cortices. Stage 3 includes mild cerebral atrophy with dilation of lateral and 
3rd ventricles, septal abnormalities, depigmentation of substantia nigra and locus 
coeruleus, atrophy of mammillary bodies, thalamus, thinning of hypothalamic floor and 
corpus callosum, and a significant presence of NFT throughout the brain. Gross 
anatomical changes in stage 4 includes all aforementioned changes with pallor of locus 
coeruleus and substantia nigra in all cases. Microscopic biomarkers include neuronal loss 
in cortex, hippocampal sclerosis, astrocytic p-tau pathology, P-tau abnormalities in 
cerebrum, diencephalon, basal ganglia, brainstem, and spinal cord, subcortical white 
matter tracts have axonal loss and distorted axonal profiles. TDP-43 immunoreactivity is 
severe. 
Clinically, stage I is possibly asymptomatic. There may be the presence of headaches, 
loss of attention and concentration, short-term memory difficulties, aggressive 
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tendencies, and depression.  Stage II is often symptomatic with depression, mood swings, 
headaches and short-term memory loss. Executive dysfunction, impulsivity, suicidality 
and language difficulties may also be present. Stage III may include memory loss, 
executive dysfunction, explosivity and difficulty with attention and concentration, 
depression, mood swings, visuospatial difficulties, aggression, and suicidality. In stage 
IV, there is executive dysfunction, memory loss and dementia in almost all cases, 
language difficulties, explosivity, aggressive tendencies, paranoia, depression, gait and 
visuospatial difficulties. Suicide does not occur at this stage. 
 
Cerebrovascular lesions as a potential biomarker for CTE 
A cerebrovascular lesion that has been observed in a cohort of brains diagnosed with 
CTE consists of arteriolar profiles with multiple internal lumens and is termed a “multi-
lumen vessel” (MLV) (personal communication: Ann McKee, Thor Stein, Patrick 
Kiernan August 2016). MLV as an indicator of cerebrovascular pathology has been 
identified in brains with age-related diseases such as brain arteriolosclerosis (Ighodaro 
2016). The mechanisms driving development of MLVs is unknown. It is hypothesized 
that MLVs can be a direct consequence of repetitive head injuries (RHIs) that may result 
in CTE or an indirect consequence of the progression of CTE pathology. A potential 
biological intermediary between MLVs and RHIs is angiogenesis. Angiogenesis is the 
established mechanism for overproliferation of new blood vessels in reaction to various 
conditions, including head trauma (Fisher 2001, Zhang 2013, Alford PW 2011, Andrews 
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AM 2016). Angiogenesis in reaction to head trauma is considered compensatory to 
restore compromised circulation as a result of altered shear stress, mechanical strain on 
vascular architecture, and decrease in perfusion due to ischemia (Fisher 2001).  
In an acute traumatic brain injury, the mechanical forces from rotational and linear 
acceleration of the brain act on points of vulnerability to torsional strain (Cantu 1996). 
The cerebrovascular architecture is particularly vulnerable to alteration as a result of the 
mechanical stress in a traumatic brain injury (Cipolla MJ 2009, Zhang Y 2013). As a 
consequence, both breakage of the blood brain barrier and shear stress that occurs within 
blood vessels during the insult may induce angiogenesis (Alford PW 2011). 
 
Other proposed mechanisms of vascular remodeling due to head trauma are cerebral 
vasospasm resulting in hypercontractility of the vessels and acute and chronic 
inflammation (Alford PW 2011). Hypercontractility is a result of cerebral vasospasm that 
Figure 1 A typical multilumen vessel 
A typical multilumen vessel is represented. The vessel 
contains evidence of both longitudinally cut and transversely 
cut lumen. The Purple arrows point to individual lumen. 
Scale bar is set to 400 micrometers. 
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commonly occurs as a result of traumatic brain injury which leads to cerebral ischemia or 
infarction (Humphrey JD 2007). Consequences of hypercontractility are mediated by 
alteration in smooth muscle cell dynamics as well as calcium level dysfunction leading to 
phenotypic switching and long-term remodeling of the vasculature (Alford PW 2011). 
Acute and chronic inflammation that may result from both a single traumatic brain injury 
and repetitive mild traumatic brain injuries may also influence the alteration of vascular 
architecture (Mapp PL 2008). Inflammation may occur directly from neuronal damage, or 
indirectly from cytokines released from inflammatory cells that activate and accumulate 
following head trauma (Salmeron K 2015). 
It is hypothesized MLVs may result from directly from RHIs and/or secondary to CTE 
pathology itself. The hypothesis was tested by manual analysis of the frequency of 
multilumen vessels and the average number of lumen per vessel in afflicted brains in 
comparison to controls. 
  
Figure 2 Sprouting angiogenesis vs. Intussusception 
Two mechanisms of angiogenesis are represented. (A) 
Represents a longitudinal cut of a vessel resulting from 
sprouting angiogenesis. (B) represents a longitudinal 
cut of a vessel resulting from intussusception. (C) 
represents two transverse views from different points 
along the vessel resulting from sprouting angiogenesis. 
(D) represents typical presentations of multilumen 
vessels in a transverse plane of section resulting from 
intussusception. 
Darker blue represents tunica intima, tunica media and 
tunica adventitia. Lighter blue represents surrounding 
parenchyma. Red represents blood in lumen. 
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SPECIFIC AIMS 
The overall aim of the project was to determine whether cerebrovasculature is more 
likely to be compromised in subjects with CTE than in Non-CTE. The type of vascular 
lesion that was quantified is termed “multilumen vessel” (MLV), and is defined as a type 
of cerebrovascular lesion characterized by the presence of more than one lumen in a 
single vessel. MLVs have already been demonstrated to be present in aged brains. It is 
hypothesized that MLVs may also result directly from RHIs or indirectly from the 
progression of CTE pathology. The hypothesis was tested by quantifying the frequency 
of MLVs in CTE and Non-CTE cases, and within those cases comparing the densities of 
the MLVs in white matter and grey matter separately. In addition, the average number of 
lumen per MLV for each subject and within a cohort was used as another variable to 
substantiate the hypothesis of MLVs serving as an indicator of CTE pathology. 
Next, models using more conservative definitions for the classification of multilumen 
vessels were assumed. The presence of bona fide MLVs served as the dependent variable 
and defined as either possessing 4 or more lumen (MLV 4+) or 3 or more lumen (MLV 
3+) in a set of predictive models. Age at death, and years of exposure were tested for 
their ability to predict the presence of MLVs. Finally, Pearson’s correlation test was used 
to demonstrate any possible connection between increasing density of MLVs and 
increasing average number of lumen per MLV to progression of CTE pathology as 
represented by stage of CTE. 
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METHODS 
Subjects 
153 slides available for the purpose of this study were taken from 153 subjects with or 
without a Non-CTE diagnosis. All slides taken from the 153 cases were from dorsolateral 
frontal cortex and stained with Luxol-fast blue and Hematoxylin and Eosin (LH&E). 
These slides were then scanned into a computer database by means of an Aperio 
SlideScanner. Out of all 153 slides scanned and analyzed, 9 were excluded from 
statistical analysis due to artefactual tearing of tissue or an inability to be digitally 
rendered. The presence of comorbid vascular disease in 19 CTE subjects and 10 Non-
CTE subjected resulted in their exclusion. Vascular disease may confound the hypothesis 
given that age-related vascular diseases, such as brain arteriosclerosis, may result in MLV 
formation. For the remaining 123 slides, 88 were taken from subjects with CTE and 35 
were from subjects with Non-CTE. 
In the CTE cohort, all 88 subjects were male. 71 played football, 5 played hockey, 4 were 
in the military, 4 were boxers, 2 played rugby, 1 played baseball, and 1 played soccer. 
The range of age at death was 74 years with the oldest subject dying at 91 years and the 
youngest with an age at death of 17. The range of years of exposure to RHIs was 29 years 
for CTE, with 30 years exposure as the longest duration and 1 year of exposure for the 
shortest. The average age at death was 61 years and the average years of exposure was 
15.  In the Non-CTE cohort, 33 subjects were male and 2 were female. 19 played 
football, 2 played hockey, 7 were in the military, 2 were boxers, 1 played rugby, 2 played 
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baseball, 4 were exposed to TBIs outside of sports, 2 were professional entertainment 
wrestlers, 2 participated in martial arts, 1 played lacrosse, 1 was a bobsledder and 1 was a 
firefighter. The range of age at death was 74 years with 88 years being the oldest and the 
14 years being the youngest. The average age at death was 46 years and the average years 
of exposure was 10.  
 CTE (n=88) Non-CTE (n=35) 
Gender 88 male 
0 female 
 
33 male 
2 female 
 
Exposure (%) Football: 71 
(81%) 
Hockey: 5 (5.7%) 
Military: 4 (4.5%)  
Boxing: 4 (4.5%) 
Rugby: 2 (2.3%) 
Baseball: 1 (1.1%) 
 
Football: 18 (51%) 
Hockey: 2 (5.7%) 
Military: 5 (14%) 
Rugby: 1 (2.9%) 
TBI(s) outside of sports: 3 (8.6%) 
Professional entertainment wrestlers: 1 
(2.9%) 
Martial arts: 2 (5.7%) 
Lacrosse: 1 (2.9%) 
Bobsledding: 1 (2.9%) 
Firefighter: 1 (2.9%) 
 
Age at death, y, 
mean ± SD 
(Range) 
 
63.8±19.2 (17-91) 
 
39.8±23.4 (14-88) 
Years of exposure 
to RHIs, y, mean 
± SD (Range) 
 
14.9±5.9 (1-30) 7.7±4.5 (0-19) 
Table 1: Demographics of subjects  
Background information on subjects used for analysis is presented in the table. 
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Data Collection 
The multilumen pathology was analyzed by means of histological observation. All slides 
were taken from dorsolateral frontal cortex (DLFC). The slides were stained using Luxol-
fast blue and Hematoxylin and Eosin (LH&E) staining methods. Slides were then 
scanned at 20X magnification into a computer database for digital observation by means 
of an Aperio ScanScope slide scanner. Scanned slides were then analyzed by means of 
Aperio ImageScope software. Observations and quantifications (areas outlined, MLVs 
counted, and lumen counted and averaged) were made while blinded to the cohort to 
which the slide belonged. 
In order to analyze slides, digital annotations on each slide were made. Using a free-hand 
pen tool on ImageScope, areas of white matter and grey matter were outlined separately 
on each slide. The areas outlined were then recorded in square millimeters into a 
Microsoft Excel spreadsheet. Within each outlined area, multilumen vessels were then 
Figure 3 A multilumen vessel containing both longitudinal 
and transverse lumen 
Although there is a longitudinally cut lumen belonging to 
this vessel, the presence of transverse lumen adjoined by 
shared endothelium allows this to be counted as 1 MLV.  
Black arrows point to individual lumen. Scale bar is set to 
400 micrometers. 
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counted manually using the Counter tool in 
ImageScope while scanning the slide at 10x 
magnification. While counting, the number of 
lumen per vessel was also counted manually. 
 
Inclusion and exclusion criterion 
Only vessels with at least one transversely cut 
lumen were counted due to inherent 
limitations in the 2-dimensional 
discrimination between a torturous 
longitudinally traveling vessel with a single 
lumen and multiple longitudinally-cut 
 
Figure 6 Cerebrovascular lesions resulting from 
other pathologies 
Top: Overproliferation of vessels resulting from 
hemangioma. Scale bar is set to 700 micrometers. 
Bottom: A lumen within a lumen formed by 
thrombosis. Scale bar is set to 200 micrometers. 
 
 
Figure 4 Longitudinally arranged transversely cut lumen 
Although there are some transverse lumen connected via 
shared adventitia, they likely all belong to a single lumen 
that travels in and out of the plane of section. Scale bar is 
set to 500 micrometers. 
 
Figure 5 Representation of features resulting in 
exclusion 
There is a false lumen with diameter of 4.246 
micrometers, less than the threshold 7 
micrometer diameter. The pink arrow points to a 
potential lumen with torn endothelium. Scale bar 
is set to 200 micrometers. 
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luminal branches sprouting from a single vessel. Vessels with one or more longitudinally-
cut lumen could be counted as long as they shared endothelium with at least one 
transversely-cut lumen and these vessels were counted as a single MLV. However, 
multiple transversely-cut lumen with organization suggestive of a single torturous vessel 
traveling in and out of the transverse plane of section were not counted as lumen 
belonging to a MLV despite connection via adventitia (See Figure 4). Vessels were also 
excluded upon evidence of a pathological or artefactual tear or folding of endothelium, 
hemorrhaging, or some other pathological alteration in vessel morphology such as 
thrombosis or hemangioma (See Figure 6). Other problems with endothelia may include 
incomplete closure between two lumen or a cut along endothelial lining leading to 
occlusion of the lumen. Endothelial-enclosed spaces with a diameter less than that of a 
Figure 7 Pial Vessels 
Purple line outlines branched and torturous vessels in subarachnoid space and penetrating pia mater. 
Scale bar is set to 400 micrometers. 
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red blood cell (about 7 micrometers) were not counted as true lumen. Parenchymal 
vessels and penetrating arteries in parenchyma were counted as they are normally 
unbranched, while vessels in subarachnoid space and pial vessels not present in 
parenchyma were not counted given that they are inherently branched and torturous (see 
Figure 7).  
 
Statistical analyses 
The data was gathered using the Aperio system and analyzed using SPSS software. 123 
total cases were used for statistical analysis, 88 from the CTE Cohort and 35 from the 
Non-CTE Cohort. To assure the robustness of the results, the areas outlined in white 
matter for the CTE and control populations were tested for their normal distribution to 
demonstrate consistency in the areas analyzed within and between populations. 
Normality was demonstrated in the areas analyzed using SPSS software, allowing for 
meaningful comparisons by eliminating the possibility of non-random influences in the 
selection of representative areas.  Significant differences between density and number of 
lumen per MLV between CTE and Non-CTE cohorts was the primary end-point of the 
study. Calculating the associations between these variables and potential predictive 
factors such as age at death and years of exposure to RHIs helped direct and give 
perspective to the analyses. Finally, the predictive value of all aforementioned variables 
for stage of CTE, while controlling for age at death and exposure, was modeled using 
ordinal logistic regression. 
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RESULTS 
Description of Variables and Comparisons Between Populations 
The sample population included 123 subjects who had experienced exposure to RHIs 
throughout their lifetime. The subjects’ brains were donated to the Boston University – 
Veteran’s Affairs – Concussion Legacy Foundation Brain Bank. This study is part of the 
National Institutes of Health-funded U01 project, entitled, “Understanding Neurologic 
Injury and Traumatic Encephalopathy (UNITE).” For a majority of brain donations, next 
of kin contacted the brain bank to donate near the time of death or following death. Other 
brain donors were referred by medical examiners, recruited by the Concussion Legacy 
Foundation, or agreed to donation during life through the Brain Donation Registry. 
Inclusion criteria were broad to optimize generalizability and only included a history of 
RHI exposure. Brain donors were excluded for poor brain and spinal cord specimen 
quality. All analyses used MLVs in white matter. Density represents the degree to which 
MLVs are present in a given subject and was quantified manually by counting all MLVs 
within outlined areas of white matter in the DLFC with a mean of .028 MLVs/mm2. The 
average number of lumen per vessel was also quantified manually using the inclusion and 
exclusion criterion mentioned in the Methods section with a mean of 2.6 lumen per MLV 
for CTE and 2.4 lumen per MLV for Non-CTE. 
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Normalization of areas of white matter analyzed in CTE and Non-CTE cases 
 
 
 
 
Areas of white matter in the DLFC for CTE and Non-CTE cases were outlined using the 
free-hand pen tool in ImageScope. Demonstrating normalization of outlined areas allows 
the total area in the population of each cohort to be analyzed in aggregate without the 
possibility of non-random selection of areas for analysis. For both CTE and Non-CTE 
cohorts, both Kolmogorov-Smironov and Shapiro-Wilk tests suggest normal distribution 
of analyzed areas given that the null hypothesis was not rejected. Aggregating the areas 
 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic Df Sig. 
Sample area .063 123 .200* .988 123 .353 
*. This is a lower bound of the true significance. 
Table 2: Test for normality in the sizes of the sample areas. The distribution of sample areas 
pass both Kolmogorov-Smirnov and Shaprio-Wilk tests for normalization with p-values of 
.200 and .353 respectively. 
Figure 8: Demonstration of normality in the sizes of selected areas 
used for analysis. Normality assures comparisons between 
populations will be meaningful and that there was no non-random 
influences on selection of area. 
17 
 
from both populations as well as randomness of selection allows for meaningful 
comparisons between the populations. 
 
Density of MLVs in white matter for CTE and Non-CTE cohorts  
88 subjects with CTE and 35 subjects with Non-CTE were analyzed for the density of 
MLVs in the white matter of the brain. Out of 88 CTE cases, 69% (61/88) cases had at 
least 1 MLV. In the Non-CTE cohort, 37% (13/35) of the subjects had at least 1 MLV. 
Student’s t-test was performed using SPSS to compare the density of MLV in both CTE 
and Non-CTE populations. The comparison of density between the two populations 
demonstrated a significant difference at a CI of 95% with a p-value of .013. There is a 
Figure 9: Box and whisker plot comparing the density of MLVs in 
CTE subjects to Non-CTE subjects. It was shown with significance 
that density is greater in the CTE cohort. 
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higher average density of MLVs in CTE cases of .028 MLV/mm2, compared to an 
average .013 MLV/mm2 for the Non-CTE population. 
 
Average number of lumen per MLV per subject in CTE and Non-CTE cohorts 
  
CTE 
 
Non-CTE 
 
Comparison of means: p-value from 
Student’s t-test 
 
Density, 
MLVs per 
mm2, 
Mean±SD 
(Range) 
 
 
.028±.028 (0-.15) 
 
.013±.023 (0-.013) 
 
0.013* 
 
Average 
number of 
lumen per 
MLV, 
Mean±SD 
(Range) 
 
 
2.6±.59 (2-4.3) 
 
2.4±.37 (2-3.0) 
 
.065 
Table 3: Description of variables measured. The density of MLVs is significantly greater in CTE cases in 
comparison to Non-CTE, while average number of lumen is not significantly greater in CTE cases. 
Figure 10: Comparing the average number of lumen per MLV 
found in CTE to the average found in Non-CTE 
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Out of the 69 CTE cases with MLVs and 13 Non-CTE cases with MLVs, the number of 
lumen per MLVs in each case and in the population was analyzed and compared between 
the cohorts.  The average number of lumen per MLV in all CTE cases was 2.6 and 2.4 in 
all Non-CTE cases. Performing Student’s t-test using SPSS, an insignificant difference 
between the cohorts was found at a confidence interval (C1) of 95% and a p-value of 
.065.  
 
Associations Between Continuous Variables using Multiple Linear Regression 
Age of Death Predicts Increased Density of MLVs 
 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
 (Constant) -.006 .006  -.874 .384 
age at death .001 .000 .465 4.797 .000*** 
years of exposure .000 .000 -.078 -.777 .439 
CTE (Y/N) .005 .006 .080 .775 .440 
Table 4: Predictive power of independent variables for density of MLVs. Years of exposure and a CTE 
diagnosis do not predict the density of MLVs, but increasing age at death significantly predicts an increase 
in density of MLVs. 
 
A multiple linear regression model was made to test which variables drive MLV 
formation. Density was used as the dependent variable with age at death, years of 
exposure to RHIs, and the presence of CTE as predictive variables. It was found that 
increased age at death significantly predicts increased MLV density at a p-value of <.001. 
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However, years of exposure and a CTE diagnosis were insignificant in their ability to 
predict MLV density (See Table 4). 
 
CTE Pathology Predicts Increased Average Number of Lumen 
 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
 (Constant) 2.414 .112  21.523 .000 
age at death .001 .002 .031 .293 .770 
years of exposure -.007 .007 -.099 -.913 .363 
CTE (Y/N) .237 .107 .250 2.217 .029*** 
Table 5: Predictive power of independent variables for average number of lumen per MLV. Age at 
death and years of exposure do not predict average number of lumen, but a CTE diagnosis significantly 
predicts an increased average number of lumen. 
 
A second multiple linear regression model was made to test which variables may cause 
progression of MLV pathology as represented by average number of lumen per MLV. It 
was found that neither age at death nor years of exposure significantly predict average 
number of lumen. However, the presence of a CTE diagnosis did significantly predict an 
increased average number of lumen per MLV at a CI of 95% (see Table 5). 
 
Adjusted Multivariate Analysis 
Age at death Predicts the presence of at least 1 MLV 
To have greater confidence in the connection between CTE and the presence of 
multilumen vessels, additional tests were performed using stricter definitions for MLVs. 
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To derive the correlation between age at death, years of exposure to RHIs, and a CTE 
diagnosis to the probability of the presence of at least one bona fide multilumen vessel, 
binary logistic regression was performed on both CTE and Non-CTE cohorts. For each 
cohort, the logistic regression was performed twice, each time with different definitions 
for MLVs. A MLV was defined as either possessing at least 4 lumen or at least 3 lumen.   
 
Binary logistic regression assuming MLVs Possess 4 or More Lumen 
 B S.E. Wald df Sig. Exp(B) 
 Age at death .031 .010 8.669 1 .003*** 1.031 
Years of exposure -.035 .037 .873 1 .350 .966 
CTE (Y/N) .676 .556 1.477 1 .224 1.967 
Constant -2.125 .637 11.118 1 .001 .119 
Table 6: Binary logistic regression model predicting MLVs with 4 or more lumen. Only age at death 
significantly predicts the presence of MLVs with 4 or more lumen. 
 
 
 Chi-square df Sig. 
 Step 15.416 3 .001 
Block 15.416 3 .001 
Model 15.416 3 .001 
Table 7: Omnibus test of model coefficients for predicting MLV 4+: 
Testing the fit the binary logistic regression model with age at 
death, years of exposure, and a CTE diagnosis as predictors of 
MLV 4+. 
 
Binary logistic regression was performed to determine the associations between age at 
death, exposure, and a CTE diagnosis to the probability of there being at least 1 MLV 4+.  
Only age at death was a significant predictor of MLV 4+ at a CI of 95% with a p-value of 
22 
 
.003 and p-values for exposure and CTE diagnosis of .350 and .224 respectively. From 
Omnibus Tests of Model Coefficients for goodness-of-fit the chi-square was found to be 
𝛘2=15.416 with a significance of p=.001. The null hypothesis of goodness-of-fit was 
rejected. 
 
Binary logistic regression assuming MLVs Possess 3 or More Lumen 
 B S.E. Wald df Sig. Exp(B) 
 age at death .029 .014 4.320 1  .038*** 1.029 
years of exposure -.082 .049 2.795 1 .095 .921 
CTE (Y/N) -1.158 .774 2.237 1 .135 .314 
Constant -1.971 1.023 3.709 1 .054 .139 
Table 8: Binary logistic regression model predicting MLVs with 3 or more lumen. The presence of a CTE 
diagnosis does not significantly predict the presence of at least 1 MLV with 3 or more lumen. Years of 
exposure is nearly significant as a predictor of at least 1 MLV with 3 or more lumen. Age at death significantly 
predicts MLV with 3 or more lumen. 
 
 
 Chi-square df Sig. 
 Step 9.478 3 .024 
Block 9.478 3 .024 
Model 9.478 3 .024 
Table 9: Omnibus test of model coefficients: Testing the fit 
the binary logistic regression model with age at death, years 
of exposure, and a CTE diagnosis as predictors of MLV 3+. 
 
Binary logistic regression was performed to determine the association between age at 
death, years of exposure to RHIs, and a CTE diagnosis to the probability of there being at 
least 1 MLV 3+. It was found only age at death is a significant predictor of MLV 3+ at a 
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CI of 95% with a p-value of .038, while exposure is nearly significant at a CI of 95% 
with a p-value of .095. A CTE diagnosis did not predict the probability of there being at 
least 1 MLV at a p-value of .135. Using chi-squared test to assess goodness-of-fit, the 
chi-squared value was found to be 𝛘2=9.478 with a p-value of .024, rejecting the null 
hypothesis of goodness-of-fit in the model. From the Omnibus Test of Model 
Coefficients for both binary logistic models, it can be assumed MLVs with 3 or more 
lumen is a more suitable definition given the fit was better than the model assuming 
MLVs possess 4 or more lumen. The poor fit of both models will discussed in the 
Discussion section. 
 
Density of MLVs but Not Average Number of Lumen is Correlated to CTE Stage  
To determine if there is any 
relationship between the 
progression of MLV pathology 
and the progression of CTE as 
represented by stage of CTE, Pearson’s correlation test was used. The correlation 
between MLV density and stage of CTE was shown to be significant at a CI of 95% 
using Pearson’s correlation test with a p-value of .010.  The Pearson Correlation 
coefficient between the variables is .281. However, the correlation between average 
number of lumen and stage of CTE was shown to be insignificant at a CI of 95% with a 
p-value of .126. The Pearson Correlation coefficient between the two variables is -.164. 
 CTE stage MLV density 
CTE stage Pearson Correlation 1 .281 
Sig. (2-tailed)  .010*** 
MLV 
density 
Pearson Correlation .281 1 
Sig. (2-tailed)  .010***  
Table 10: Pearson’s correlation test: CTE stage and MLV density 
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More MLVs Are Found in the Grey Matter of CTE Subjects 
Out of the 88 CTE cases, 19% (17/88) contained MLVs in grey matter. This is in 
comparison to Non-CTE cases where only 11% (4/35) of the cases contained MLVs in 
the grey matter. Because of the statistical limitations of a sample size of 4, there could be 
no further analysis of MLVs in grey matter. 
 
 
 
 
  
 
 
 
 CTE stage Average number of lumen 
CTE stage Pearson 
Correlation 
1 -.164 
Sig. (2-tailed)  .126 
 Average number 
of lumen 
Pearson 
Correlation 
-.164 1 
 
Sig. (2-tailed) .126  
Table 11: Pearson’s correlation test: CTE stage and average number of lumen 
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DISCUSSION 
Many pathological clinical, anatomical, and histological effects of chronic exposure to  
concussive and subconcussive events have already been established in the study of CTE. 
However, to date no studies have attempted to quantify the pathology of multilumen 
vessels resulting from CTE. The purpose of this analysis was to demonstrate if MLVs, 
which have already been demonstrated in aged brains, are significantly overrepresented 
in brains diagnosed with CTE. 
To demonstrate robustness of the findings, the consistency in the size of the areas 
outlined had to be established. There was normal distribution of the areas outlined in 
CTE and Non-CTE population, demonstrating consistency in the size of selected samples 
of white matter allowing for meaningful comparisons between populations and 
eliminating the possibility of non-random selection. 
 
Density of MLVs in white matter in brains from CTE and Non-CTE cohorts 
The findings from the analysis of density of MLVs support the hypothesis of multilumen 
pathology resulting from RHIs. First, only 11% (4/35) of Non-CTE cases contained any 
MLVs in grey matter while 19% (17/88) of CTE cases contained MLVs in the grey 
matter. Although no statistical analysis could be performed using these findings, the 
increased frequency of MLVs in grey matter of CTE cases is worth noting. Next, it was 
demonstrated that there is both a greater frequency and a greater density of MLVs in the 
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CTE population in comparison to the Non-CTE population. This suggests that subjects 
with CTE are more frequently afflicted with MLVs than subjects without CTE. The data 
also suggests that there are also more MLVs per square millimeter in the CTE cohort than 
the Non-CTE cohort. 
For deeper insight into how density of MLVs may be an indicator of CTE, associations 
between density and age at death, years of exposure to RHIs, and a CTE diagnosis were 
made. Analysis using multiple linear regression demonstrates a significant association 
between density and age at death in both CTE and Non-CTE populations. Given that a 
CTE diagnosis does not predict an increased MLV density, it can be assumed that an 
increased density of MLVs is not reflective of CTE pathology alone. The associations 
suggest that MLVs may become more frequent with normal aging or other pathologies, 
and the rate of increase of MLVs is positively impacted by CTE.  
Surprisingly, there was no significant association between density of MLVs and years of 
exposure to RHIs, although there was a slight positive trend. This may suggest MLVs do 
not form at a faster rate as a direct consequence to an accumulation of head impacts, but 
perhaps as an indirect consequence of CTE along with some other variable associated 
with increased age. 
 
Average number of lumen per MLV in CTE and Non-CTE cohorts 
The average number of lumen per MLV in the CTE cohort was greater than that of the 
Non-CTE cohort, but the difference between the means was demonstrated to be 
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insignificant using Student’s t-test. However, a nearly significant p-value of .065 suggests 
a positive trend towards a higher average that may become significant with more data. 
For both CTE and Non-CTE populations there were insignificant associations between 
average number of lumen and age at death as well as average number of lumen and 
exposure. However, the presence of a CTE diagnosis did significantly predict an 
increased average number of lumen per MLV. This furthers the hypothesis that MLVs are 
secondary to other indicators of CTE pathology rather than a direct result of RHIs. 
 
Age at Death is a Significant Predictor of the Presence of at Least 1 MLV 
To have greater confidence in the results, stricter definitions were applied to what counts 
as a multilumen vessel. Factors that are likely to increase the probability of the presence 
of a MLV are age at death, exposure to RHIs, and a CTE diagnosis. For this reason, a 
predictive model using binary logistic regression was run to see how age at death, 
exposure, and a CTE diagnosis affect the probability of the presence of at least 1 MLV. 
This test was run twice, once for where a MLV was defined as possessing 4 or more 
lumen, and another as 3 or more lumen. In the model where a MLV was defined as 
possessing 4 or more lumen, only age at death was found to be a predictor of MLVs, 
while exposure and a CTE diagnosis were both insignificant. When MLVs were defined 
as having 3 or more lumen, age at death significantly predicts MLV 3+, while exposure 
was nearly significant. A CTE diagnosis was insignificant in its ability to predict a MLV 
3+. The latter model of MLVs possessing 3 or more lumen was assumed to be more 
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correct given the better fit. It should be noted that in the cases where the goodness-of-fit 
test failed, the test is sensitive to large sample size so it does not entirely discredit the 
models. 
 
Using MLVs to predict stage of CTE 
The potential for density of MLVs and average number of lumen per MLV to increase 
with increments of CTE stage was analyzed. Pearson’s correlation test was used to 
analyze a possible connection between the progression of MLV pathology and the 
progression of CTE as represented by CTE stage.  It was found that increasing density of 
MLVs, but not average number of lumen per MLV, was significantly correlated to 
incremental stages of CTE. 
 
Limitations in data collection 
There were a few limitations in the extent to which data could be gathered for 
quantification. Only the dorsolateral frontal cortex (DLFC) was analyzed as a 
representative area vulnerable to MLVs. Additional brain regions may help refine the 
understanding of the observable qualities of MLVs and their relationship to CTE. The 
number of slides available for scanning and subsequent analysis was high enough to 
reach statistical significance but confidence in results may improve with a greater sample 
size. In addition, the number of Non-CTE cases in all slides available was relatively 
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underrepresented. Other issues with data collection could be associated with procedural 
error in appropriately identifying MLVs and their observable features. 
 
Implications for future research 
In addition to furthering the findings of this project with a larger sample size, there are a 
few other possible routes of exploration. Greater confidence in the results would be 
offered by including supportive features of CTE to the analysis, such as identifying the 
presence of perivascular tau deposits with the MLVs. Repeating the analysis in additional 
brain regions such as the cerebellum or hippocampus would also provide context and 
possible controls within a subject. Controlling for features of exposure, such as sport 
played, could provide a deeper understanding of the results. 
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